Evidence map›Paper›PMID 25060789›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2014

Diversity is in my veins: role of bone morphogenetic protein signaling during venous morphogenesis in zebrafish illustrates the heterogeneity within endothelial cells.

Jun-Dae Kim, Heon-Woo Lee, Suk-Won Jin

Open access · greenAbstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Transcriptomic analysis identifies novel targets for individual bone morphogenetic protein type 1 receptors in endothelial cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. LRP in Endothelial Cells: A Little Goes a Long Way.Arteriosclerosis, thrombosis, and vascular biology · 2016
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jun-Dae KimFrom the Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.-D.K., H.W.L., S.-W.J.) and Department of Internal Medicine (J.-D.K., H.W.L., S.-W.J.), Yale University School of Medicine, New Haven, CT; and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea (S.-W.J.).
Heon-Woo LeeFrom the Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.-D.K., H.W.L., S.-W.J.) and Department of Internal Medicine (J.-D.K., H.W.L., S.-W.J.), Yale University School of Medicine, New Haven, CT; and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea (S.-W.J.).
Suk-Won JinFrom the Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.-D.K., H.W.L., S.-W.J.) and Department of Internal Medicine (J.-D.K., H.W.L., S.-W.J.), Yale University School of Medicine, New Haven, CT; and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea (S.-W.J.). suk-won.jin@yale.edu sukwonjin@gist.ac.kr.
Gwangju Institute of Science and Technology · KR

Funding

Endothelial lineage specification and differentiation in vertebrate embryosR01HL090960 · NHLBI · YALE UNIVERSITY · PI JIN, SUK-WON · 2008 to 2013
$2.1M
Bone Morphogenic Protein Signaling in Lymphatic Endothelial CellsR01HL114820 · NHLBI · YALE UNIVERSITY · PI JIN, SUK-WON · 2013 to 2016
$1.8M
NHLBI NIH HHS HL090960NHLBI NIH HHS HL119345NHLBI NIH HHS R01 HL090960NHLBI NIH HHS R01 HL114820
6 · The paper itself

Abstract

Endothelial cells are a highly diverse group of cells which display distinct cellular responses to exogenous stimuli. Although the aptly named vascular endothelial growth factor-A signaling pathway is hailed as the most important signaling input for endothelial cells, additional factors also participate in regulating diverse aspects of endothelial behaviors and functions. Given this heterogeneity, these additional factors seem to play a critical role in creating a custom-tailored environment to regulate behaviors and functions of distinct subgroups of endothelial cells. For instance, molecular cues that modulate morphogenesis of arterial vascular beds can be distinct from those that govern morphogenesis of venous vascular beds. Recently, we have found that bone morphogenetic protein signaling selectively promotes angiogenesis from venous vascular beds without eliciting similar responses from arterial vascular beds in zebrafish, indicating that bone morphogenetic protein signaling functions as a context-dependent regulator during vascular morphogenesis. In this review, we will provide an overview of the molecular mechanisms that underlie proangiogenic effects of bone morphogenetic protein signaling on venous vascular beds in the context of endothelial heterogeneity and suggest a more comprehensive picture of the molecular mechanisms of vascular morphogenesis during development.

Indexed as

AnimalsBone Morphogenetic Protein ReceptorsBone Morphogenetic ProteinsEndothelial CellsMesodermMiceNeovascularization, PhysiologicOrgan SpecificityReceptors, NotchSignal TransductionSmad ProteinsSpecies SpecificityVascular Endothelial Growth Factor AVeinsZebrafishZebrafish ProteinsBone Morphogenetic Protein ReceptorsBone Morphogenetic ProteinsReceptors, NotchSmad ProteinsVascular Endothelial Growth Factor AVegfaa protein, zebrafishZebrafish Proteinsbone morphogenetic protein receptorsvascular endothelial cellsveinszebrafish

Identifiers

PMID25060789
PMCPMC4140958
OpenAlexW2521742360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.